- Home
- KALA vs VRAR Comparison
KALA vs VRAR Comparison
Compare KALA & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- VRAR
- Stock Information
- Founded
- KALA 2009
- VRAR 2016
- Country
- KALA United States
- VRAR United States
- Employees
- KALA N/A
- VRAR N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- VRAR Retail: Computer Software & Peripheral Equipment
- Sector
- KALA Health Care
- VRAR Technology
- Exchange
- KALA Nasdaq
- VRAR Nasdaq
- Market Cap
- KALA 26.2M
- VRAR 31.5M
- IPO Year
- KALA 2017
- VRAR 2021
- Fundamental
- Price
- KALA $7.86
- VRAR $1.52
- Analyst Decision
- KALA Strong Buy
- VRAR Strong Buy
- Analyst Count
- KALA 3
- VRAR 1
- Target Price
- KALA $14.00
- VRAR $2.62
- AVG Volume (30 Days)
- KALA 204.0K
- VRAR 964.2K
- Earning Date
- KALA 08-05-2025
- VRAR 05-15-2025
- Dividend Yield
- KALA N/A
- VRAR N/A
- EPS Growth
- KALA N/A
- VRAR N/A
- EPS
- KALA N/A
- VRAR N/A
- Revenue
- KALA N/A
- VRAR $8,756,789.00
- Revenue This Year
- KALA N/A
- VRAR $23.96
- Revenue Next Year
- KALA N/A
- VRAR $12.15
- P/E Ratio
- KALA N/A
- VRAR N/A
- Revenue Growth
- KALA N/A
- VRAR N/A
- 52 Week Low
- KALA $2.92
- VRAR $0.50
- 52 Week High
- KALA $11.20
- VRAR $7.00
- Technical
- Relative Strength Index (RSI)
- KALA 74.24
- VRAR 55.07
- Support Level
- KALA $5.35
- VRAR $1.52
- Resistance Level
- KALA $8.49
- VRAR $1.77
- Average True Range (ATR)
- KALA 0.79
- VRAR 0.16
- MACD
- KALA 0.24
- VRAR 0.01
- Stochastic Oscillator
- KALA 97.13
- VRAR 59.09
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.